HCM
CTIC

Highbridge Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Highbridge Capital Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-12,841
Closed -$311K – 1667
2014
Q3 		$311K Buy
+12,841
New +$334K ﹤0.01% 993

Other funds holding CTIC

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Highbridge Capital Management's CTIC Position: Q4 2014 in Review

Highbridge Capital Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2014, closing a stake of 12,841 shares — an estimated $311K sold.

Highbridge Capital Management first reported a position in CTIC in Q3 2014 and held it in 1 quarter. The position peaked at $311K in Q3 2014. 90 funds tracked by Wall St. Rank hold CTIC as of Q4 2014.

  • Highbridge Capital Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q4 2014 after selling out during the quarter.
  • Highbridge Capital Management sold 12,841 CTI BioPharma Corp. (DE) Common Stock shares in Q4 2014, an estimated $311K.
  • Highbridge Capital Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2014 and held it in 1 quarter.
  • Highbridge Capital Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $311K in Q3 2014.
  • 90 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2014.

Based on Highbridge Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.